Vor Biopharma
VOR
VOR
48 hedge funds and large institutions have $125M invested in Vor Biopharma in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
0.83%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
13
Reduced
11
Closed
9
Calls
$31K
Puts
$20K
Net Calls
+$11K
Net Calls Change
-$1K
Top Buyers
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
$6.78M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
$5.83M |
| 3 |
ABG
Ally Bridge Group
New York
|
$1.02M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
$834K |
| 5 |
Millennium Management
New York
|
$1.35M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
State of Wisconsin Investment Board
Madison,
Wisconsin
| – | -$54K | -10,800 | Closed |
|
52
UBS Group
Zurich,
Switzerland
| – | -$4K | -865 | Closed |
|
53
New York State Common Retirement Fund
Albany,
New York
| – | -$1K | -190 | Closed |
|